We're always on the lookout for local news relevant to the communities of Highland Perthshire.
Have you got a news story you think we should know about?

Perth Royal Infirmary Introduces New Bronchoscopy Test

Respiratory patients living in Highland Perthshire can now access a new specialist bronchoscopy test at the Perth Royal Infirmary (PRI).

The Endobronchial ultrasound scan with transbronchial needle aspiration (EBUS TBNA) test, was previously available to patients at Ninewells Hospital, but thanks to the recruitment of a respiratory consultant as part of the EBUS TBNA service at Perth Royal Infirmary, which is run once a week by a doctor and nursing team, patients have been able to get the necessary treatment closer to home.  

Respiratory Consultant, Dr Mark Spears, said: “Endobronchial ultrasound sampling (EBUS) of glands within the chest is of critical importance for the diagnosis of, and planning of care for cancer patients.

“Until recently, this service was only available at Ninewells Hospital, resulting in patients having to travel from the Perthshire area for this test. However, following investment in equipment and training of endoscopy staff, and the recruitment of a respiratory consultant trained in the technique, PRI recently launched its EBUS service.

 “This exciting service development provides resilience to the lung cancer pathway within NHS Tayside and demonstrates our ongoing commitment to the improvement of services for patients, development of staff, and reduction of the carbon footprint associated with delivery of care, including provision of care closer to the patients home where possible.”

The EBUS TBNA test is available for lung cancer and respiratory patients and allows the endoscopy team to use equipment with ultrasound capabilities to examine a patients airways. Through this test, the team are able to detect and sample lymph nodes which allows them to develop and inform a patients treatment plan.

The treatment was first made available at Perth Royal Infirmary last year with the first patient receiving the test in November.

Scroll to Top